GPR22

gene
On this page

Summary

GPR22 (G protein-coupled receptor 22, HGNC:4477) is a protein-coding gene on chromosome 7q22.3, encoding G-protein coupled receptor 22 (Q99680). Orphan G-protein coupled receptor.

This gene is a member of the G-protein coupled receptor 1 family and encodes a multi-pass membrane protein.

Source: NCBI Gene 2845 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 3 total
  • Druggable target: yes
  • MANE Select transcript: NM_005295

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4477
Approved symbolGPR22
NameG protein-coupled receptor 22
Location7q22.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000172209
Ensembl biotypeprotein_coding
OMIM601910
Entrez2845

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000304402, ENST00000473300, ENST00000496754, ENST00000890166, ENST00000960458, ENST00000960459

RefSeq mRNA: 1 — MANE Select: NM_005295 NM_005295

CCDS: CCDS5744

Canonical transcript exons

ENST00000304402 — 3 exons

ExonStartEnd
ENSE00001174047107474035107475684
ENSE00001413461107471372107472302
ENSE00001414143107470057107470445

Expression profiles

Bgee: expression breadth ubiquitous, 113 present calls, max score 95.24.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.8244 / max 172.2434, expressed in 130 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
804431.5695124
804440.196575
2046430.058434

Top tissues by expression

127 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534395.24gold quality
superior frontal gyrusUBERON:000266189.87gold quality
prefrontal cortexUBERON:000045186.30gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.46gold quality
dorsolateral prefrontal cortexUBERON:000983484.70gold quality
Brodmann (1909) area 9UBERON:001354084.60gold quality
frontal cortexUBERON:000187084.36gold quality
cerebral cortexUBERON:000095683.44gold quality
anterior cingulate cortexUBERON:000983582.91gold quality
primary visual cortexUBERON:000243681.70gold quality
right frontal lobeUBERON:000281081.05gold quality
heart left ventricleUBERON:000208480.23gold quality
Ammon’s hornUBERON:000195479.51gold quality
cardiac atriumUBERON:000208179.13gold quality
right atrium auricular regionUBERON:000663179.13gold quality
corpus callosumUBERON:000233676.97gold quality
cerebellar cortexUBERON:000212976.65gold quality
cerebellumUBERON:000203776.52gold quality
cerebellar hemisphereUBERON:000224576.43gold quality
right hemisphere of cerebellumUBERON:001489076.09gold quality
heartUBERON:000094875.88gold quality
amygdalaUBERON:000187675.18gold quality
temporal lobeUBERON:000187175.17gold quality
brainUBERON:000095573.11gold quality
adrenal tissueUBERON:001830372.76gold quality
apex of heartUBERON:000209872.56gold quality
caudate nucleusUBERON:000187367.74gold quality
bone marrow cellCL:000209267.42silver quality
calcaneal tendonUBERON:000370166.99gold quality
ventricular zoneUBERON:000305366.41gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-6075no460.83
E-ANND-3no1.20

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

81 targeting GPR22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-4262100.0073.263931
HSA-MIR-190A-3P100.0080.355520
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-34A-5P99.9971.211784
HSA-MIR-449A99.9971.051776
HSA-MIR-318599.9968.121959
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-4789-5P99.9870.762721
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-34C-5P99.9770.451577
HSA-MIR-449B-5P99.9770.261580
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-96-5P99.9572.802140
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163

Literature-anchored findings (GeneRIF, showing 2)

  • Demonstrate GRR22 expression in human heart. (PMID:18539757)
  • Cardiomyocyte-specific overexpression of GPR22 ameliorates cardiac injury in mice with acute myocardial infarction. (PMID:38816768)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriogpr22aENSDARG00000004592
danio_reriogpr22bENSDARG00000045383
mus_musculusGpr22ENSMUSG00000044067
rattus_norvegicusGpr22ENSRNOG00000008423
drosophila_melanogasterCrzRFBGN0036278
caenorhabditis_elegansWBGENE00013642

Paralogs (16): NPFFR2 (ENSG00000056291), GNRHR (ENSG00000109163), CCKBR (ENSG00000110148), HCRTR1 (ENSG00000121764), AVPR2 (ENSG00000126895), GALR3 (ENSG00000128310), HCRTR2 (ENSG00000137252), NPFFR1 (ENSG00000148734), CCKAR (ENSG00000163394), AVPR1A (ENSG00000166148), GALR1 (ENSG00000166573), GPR150 (ENSG00000178015), OXTR (ENSG00000180914), FFAR4 (ENSG00000186188), QRFPR (ENSG00000186867), AVPR1B (ENSG00000198049)

Protein

Protein identifiers

G-protein coupled receptor 22Q99680 (reviewed: Q99680)

All UniProt accessions (1): Q99680

UniProt curated annotations — full annotation on UniProt →

Function. Orphan G-protein coupled receptor. Seems to act through a G(i)/G(o) mediated pathway. May be involved in ciliogenesis.

Subcellular location. Cell membrane.

Tissue specificity. High expression in adult and fetal heart tissue. Expressed in the brain, with enrichment in the accumbens, amygdala, cerebellum, cortex, and hippocampus regions.

Similarity. Belongs to the G-protein coupled receptor 1 family.

RefSeq proteins (1): NP_005286* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000276GPCR_RhodpsnFamily
IPR017452GPCR_Rhodpsn_7TMDomain

Pfam: PF00001

UniProt features (19 total): topological domain 8, transmembrane region 7, glycosylation site 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q99680-F172.190.32

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 16, 192

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 108 (showing top): WWTAAGGC_UNKNOWN, LHX3_01, EFC_Q6, EVI1_05, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, WTGAAAT_UNKNOWN, TGACATY_UNKNOWN, GOBP_RESPONSE_TO_HORMONE, AACTTT_UNKNOWN, GOBP_CELL_PROJECTION_ORGANIZATION, MYB_Q5_01, TGGAAA_NFAT_Q4_01, TAATTA_CHX10_01, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED

GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), cell projection organization (GO:0030030), cellular response to hormone stimulus (GO:0032870), signal transduction (GO:0007165)

GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
G protein-coupled receptor activity1
signal transduction1
cellular component organization1
response to hormone1
cellular response to chemical stimulus1
cellular response to endogenous stimulus1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

754 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GPR22GPR20Q99678974
GPR22LPAR4Q99677864
GPR22CMKLR2P46091816
GPR22DUS4LO95620733
GPR22COG5Q9UP83699
GPR22BCAP29Q9UHQ4644
GPR22SSTP01166520
GPR22PRKAR2BP31323503
GPR22GPR142Q7Z601503
GPR22CCDC174Q6PII3487
GPR22GPR63Q9BZJ6483
GPR22GPR176Q14439483
GPR22GPR19Q15760467
GPR22GPR162Q16538456
GPR22MCF2LO15068443

IntAct

5 interactions, top by confidence:

ABTypeScore
GPR22CEBPEpsi-mi:“MI:0915”(physical association)0.370
NFATC4GPR22psi-mi:“MI:0915”(physical association)0.370
GPR22TFAP2Cpsi-mi:“MI:0915”(physical association)0.370
ARGLU1PIAS2psi-mi:“MI:2364”(proximity)0.270

BioGRID (3): NFATC4 (Two-hybrid), TFAP2C (Two-hybrid), GPR22 (Two-hybrid)

ESM2 similar proteins: A0A2R9YJI3, B2ZHY2, B3DM66, B4XF06, D4A3U0, O02777, O43194, O46635, P08909, P08911, P0C0W8, P14842, P18599, P20272, P21554, P28223, P28335, P32240, P34311, P34968, P35363, P47746, P50128, P50129, P56971, P70259, Q09502, Q333S9, Q5IS53, Q5IS66, Q5IS73, Q5IS98, Q5R4Q6, Q5U431, Q60F97, Q6DWJ6, Q71SP5, Q75Z89, Q801M1, Q80UC8

Diamond homologs: A0A2R9YJI3, D4A3U0, Q8BZL4, Q99680

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

3 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

344 predictions. Top by Δscore:

VariantEffectΔscore
7:107471370:A:Gacceptor_gain1.0000
7:107470443:GAG:Gdonor_gain0.9900
7:107471367:ACAAG:Aacceptor_gain0.9900
7:107471369:A:AGacceptor_gain0.9900
7:107471369:AAG:Aacceptor_gain0.9900
7:107471369:AAGG:Aacceptor_gain0.9900
7:107471511:GGAA:Gdonor_gain0.9900
7:107474033:A:AGacceptor_gain0.9900
7:107474034:G:GGacceptor_gain0.9900
7:107470442:AGAGG:Adonor_loss0.9800
7:107470444:AGG:Adonor_loss0.9800
7:107470446:G:GCdonor_loss0.9800
7:107470447:T:Adonor_loss0.9800
7:107474029:TTCTA:Tacceptor_loss0.9800
7:107474030:TCTA:Tacceptor_loss0.9800
7:107474031:CTA:Cacceptor_loss0.9800
7:107474032:TAGGG:Tacceptor_loss0.9800
7:107474033:A:Cacceptor_loss0.9800
7:107471367:A:AGacceptor_gain0.9700
7:107471368:C:Gacceptor_gain0.9700
7:107474033:AG:Aacceptor_gain0.9700
7:107474034:GG:Gacceptor_gain0.9700
7:107474080:T:TAacceptor_gain0.9700
7:107470446:G:GGdonor_gain0.9600
7:107472059:T:Gacceptor_gain0.9600
7:107474034:GGGA:Gacceptor_gain0.9500
7:107471498:GAGT:Gdonor_gain0.9400
7:107471755:G:GTdonor_gain0.9400
7:107474575:T:Adonor_gain0.9400
7:107471370:AG:Aacceptor_gain0.9300

AlphaMissense

2845 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:107474223:G:AG55R0.999
7:107474223:G:CG55R0.999
7:107474224:G:AG55E0.999
7:107474232:A:CS58R0.999
7:107474234:C:AS58R0.999
7:107474234:C:GS58R0.999
7:107474311:T:CL84P0.999
7:107474323:A:CD88A0.999
7:107474323:A:TD88V0.999
7:107475024:T:CF322L0.999
7:107475026:T:AF322L0.999
7:107475026:T:GF322L0.999
7:107475036:T:AW326R0.999
7:107475036:T:CW326R0.999
7:107475043:C:GP328R0.999
7:107475151:C:AP364H0.999
7:107475151:C:GP364R0.999
7:107474237:C:AN59K0.998
7:107474237:C:GN59K0.998
7:107474289:A:CS77R0.998
7:107474291:T:AS77R0.998
7:107474291:T:GS77R0.998
7:107474334:T:CC92R0.998
7:107474436:A:CS126R0.998
7:107474438:T:AS126R0.998
7:107474438:T:GS126R0.998
7:107474479:G:CR140T0.998
7:107474480:A:CR140S0.998
7:107474480:A:TR140S0.998
7:107474481:T:GY141D0.998

dbSNP variants (sampled 300 via entrez): RS1000598964 (7:107469638 A>G), RS1000699137 (7:107477228 A>G), RS1000723431 (7:107476857 T>C,G), RS1000928679 (7:107469839 T>A), RS1001663807 (7:107470157 C>A,G), RS1001814651 (7:107476822 T>A), RS1002430620 (7:107469215 T>C), RS1002872265 (7:107468951 G>A), RS1004165862 (7:107471972 T>A,C), RS1004631495 (7:107478191 T>C), RS1004808754 (7:107473571 C>G), RS1004882596 (7:107471840 A>G), RS1005182852 (7:107473934 A>C), RS1005467435 (7:107470211 A>G), RS1006169838 (7:107478242 A>G)

Disease associations

OMIM: gene MIM:601910 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST005956_26Waist-to-hip ratio adjusted for BMI2.000000e-08
GCST005962_48Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)2.000000e-06
GCST90013406_282Liver enzyme levels (alkaline phosphatase)1.000000e-25

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement
EFO:0004533alkaline phosphatase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523914 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Class A Orphans with no pharmacology

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
Doxorubicindecreases expression2
sodium arseniteincreases expression1
perfluorooctanoic aciddecreases expression1
perfluorooctane sulfonic aciddecreases expression1
pentabromodiphenyl etherdecreases expression1
perfluoro-n-nonanoic aciddecreases expression1
entinostatdecreases expression1
perfluorohexanesulfonic aciddecreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
Sunitinibdecreases expression1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Estradiolincreases expression1
Thimerosalincreases expression1
Valproic Aciddecreases expression1
8-Bromo Cyclic Adenosine Monophosphatedecreases expression1
Thapsigarginincreases expression1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4883440BindingPRESTO-Tango GPCRome screening (GPR22)Data for DCP probe UCSF924

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_LA42PathHunter U2OS GPR22 beta-arrestinCancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.